{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T17:36:16Z","timestamp":1781631376864,"version":"3.54.5"},"reference-count":53,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,30]],"date-time":"2024-01-30T00:00:00Z","timestamp":1706572800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004587","name":"Carlos III Health Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1016\/j.pnpbp.2024.110955","type":"journal-article","created":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T11:41:22Z","timestamp":1706787682000},"page":"110955","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Effects of the PAM of mGluR2, JNJ-46356479, on brain apoptotic protein levels in a mouse model of schizophrenia"],"prefix":"10.1016","volume":"131","author":[{"given":"David","family":"Olivares-Berjaga","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albert","family":"Mart\u00ednez-Pinte\u00f1o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalia","family":"Rodr\u00edguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Santiago","family":"Madero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lluc\u00eda","family":"Prohens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene","family":"Mart\u00ednez-Serrano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergi","family":"Mas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Constanza","family":"Mor\u00e9n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduard","family":"Parellada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"Gass\u00f3","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.pnpbp.2024.110955_bb0005","doi-asserted-by":"crossref","DOI":"10.1038\/tp.2015.122","article-title":"Apoptotic markers in cultured fibroblasts correlate with brain metabolites and regional brain volume in antipsychotic-naive first-episode schizophrenia and healthy controls","volume":"5","author":"Batalla","year":"2015","journal-title":"Transl. Psychiatry"},{"issue":"3","key":"10.1016\/j.pnpbp.2024.110955_bb0010","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.pneurobio.2011.08.003","article-title":"Schizophrenia: susceptibility genes, dendritic-spine pathology and gray matter loss","volume":"95","author":"Bennett","year":"2011","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.pnpbp.2024.110955_bb0015","first-page":"1261","article-title":"Increased serum levels of apoptosis in deficit syndrome schizophrenia patients: a preliminary study","volume":"12","author":"Beyazy\u00fcz","year":"2016","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"10.1016\/j.pnpbp.2024.110955_bb0020","doi-asserted-by":"crossref","first-page":"8848015","DOI":"10.1155\/2021\/8848015","article-title":"Pretreatment with mGluR2 or mGluR3 agonists reduces apoptosis induced by hypoxia-ischemia in neonatal rat brains","volume":"2021","author":"Bratek-Gerej","year":"2021","journal-title":"Oxidative Med. Cell. Longev."},{"issue":"13","key":"10.1016\/j.pnpbp.2024.110955_bb0025","doi-asserted-by":"crossref","first-page":"7000","DOI":"10.3390\/ijms23137000","article-title":"Group II metabotropic glutamate receptors reduce apoptosis and regulate BDNF and GDNF levels in hypoxic-ischemic injury in neonatal rats","volume":"23","author":"Bratek-Gerej","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"18","key":"10.1016\/j.pnpbp.2024.110955_bb0030","doi-asserted-by":"crossref","first-page":"8495","DOI":"10.1021\/acs.jmedchem.6b00913","article-title":"Discovery of 8-Trifluoromethyl-3-cyclopropylmethyl-7-[(4-(2,4-difluorophenyl)-1-piperazinyl)methyl]-1,2,4-triazolo[4,3-a]pyridine (JNJ-46356479), a selective and orally bioavailable mGlu2 receptor positive allosteric modulator (PAM)","volume":"59","author":"Cid","year":"2016","journal-title":"J. Med. Chem."},{"issue":"6","key":"10.1016\/j.pnpbp.2024.110955_bb0035","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.biopsych.2022.03.002","article-title":"Cognitive dysfunction and prefrontal cortical circuit alterations in schizophrenia: developmental trajectories","volume":"92","author":"Dienel","year":"2022","journal-title":"Biol. Psychiatry"},{"issue":"1","key":"10.1016\/j.pnpbp.2024.110955_bb0040","doi-asserted-by":"crossref","first-page":"171","DOI":"10.9758\/cpn.2023.21.1.171","article-title":"Evaluation expression of the Caspase-3 and Caspase-9 apoptotic genes in schizophrenia patients","volume":"21","author":"Dirican","year":"2023","journal-title":"Clin. Psychopharmacol. Neurosci."},{"issue":"3","key":"10.1016\/j.pnpbp.2024.110955_bb0045","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1093\/schbul\/sbn187","article-title":"The neurodevelopmental hypothesis of schizophrenia, revisited","volume":"35","author":"Fatemi","year":"2009","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.pnpbp.2024.110955_bb0050","article-title":"Apoptotic proteins in the temporal cortex in schizophrenia: high Bax\/Bcl-2 ratio without Caspase-3 activation","volume":"161","author":"Fredrik Jarskog","year":"2004","journal-title":"Am. J. Psychiatry"},{"issue":"1","key":"10.1016\/j.pnpbp.2024.110955_bb0055","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.pnpbp.2011.08.010","article-title":"Neurotoxic\/neuroprotective activity of haloperidol, risperidone and paliperidone in neuroblastoma cells","volume":"36","author":"Gass\u00f3","year":"2012","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"issue":"1","key":"10.1016\/j.pnpbp.2024.110955_bb0060","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.jpsychires.2013.09.017","article-title":"Increased susceptibility to apoptosis in cultured fibroblasts from antipsychotic-na\u00efve first-episode schizophrenia patients","volume":"48","author":"Gass\u00f3","year":"2014","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.pnpbp.2024.110955_bb0065","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.jpsychires.2017.08.003","article-title":"Microarray gene-expression study in fibroblast and lymphoblastoid cell lines from antipsychotic-na\u00efve first-episode schizophrenia patients","volume":"95","author":"Gass\u00f3","year":"2017","journal-title":"J. Psychiatr. Res."},{"issue":"3","key":"10.1016\/j.pnpbp.2024.110955_bb0070","doi-asserted-by":"crossref","first-page":"2054","DOI":"10.3390\/ijms24032054","article-title":"Neurotoxic\/neuroprotective effects of clozapine and the positive allosteric modulator of mGluR2 JNJ-46356479 in human neuroblastoma cell cultures","volume":"24","author":"Gass\u00f3","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.pnpbp.2024.110955_bb0075","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1093\/schbul\/sbp006","article-title":"The dopamine hypothesis of schizophrenia: version III - the final common pathway","volume":"35","author":"Howes","year":"2009","journal-title":"Schizophr. Bull."},{"issue":"4","key":"10.1016\/j.pnpbp.2024.110955_bb0080","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1111\/j.1527-3458.2007.00024.x","article-title":"The preclinical properties of a novel group II metabotropic glutamate receptor agonist LY379268","volume":"13","author":"Imre","year":"2007","journal-title":"CNS Drug Rev."},{"issue":"7","key":"10.1016\/j.pnpbp.2024.110955_bb0085","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1007\/s00406-015-0649-2","article-title":"Minocycline exacerbates apoptotic neurodegeneration induced by the NMDA receptor antagonist MK-801 in the early postnatal mouse brain","volume":"266","author":"Inta","year":"2016","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci."},{"key":"10.1016\/j.pnpbp.2024.110955_bb0090","doi-asserted-by":"crossref","DOI":"10.1016\/S0006-3223(00)00988-4","article-title":"Cortical Bcl-2 protein expression and apoptotic regulation in schizophrenia","volume":"48","author":"Jarskog","year":"2000","journal-title":"Biol. Psychiatry"},{"issue":"1","key":"10.1016\/j.pnpbp.2024.110955_bb0095","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1038\/sj.npp.1301074","article-title":"Caspase-3 activation in rat frontal cortex following treatment with typical and atypical antipsychotics","volume":"32","author":"Jarskog","year":"2007","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pnpbp.2024.110955_bb0100","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.bbr.2015.01.010","article-title":"Ketamine administration during the second postnatal week induces enduring schizophrenia-like behavioral symptoms and reduces parvalbumin expression in the medial prefrontal cortex of adult mice","volume":"282","author":"Jeevakumar","year":"2015","journal-title":"Behav. Brain Res."},{"issue":"4","key":"10.1016\/j.pnpbp.2024.110955_bb0105","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1177\/0963721410377601","article-title":"Structural and functional brain abnormalities in schizophrenia","volume":"19","author":"Karlsgodt","year":"2010","journal-title":"Curr. Dir. Psychol. Sci."},{"issue":"1","key":"10.1016\/j.pnpbp.2024.110955_bb0110","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1002\/j.2051-5545.2008.tb00142.x","article-title":"Should cognitive impairment be included in the diagnostic criteria for schizophrenia?","volume":"7","author":"Keefe","year":"2008","journal-title":"World Psychiatry"},{"issue":"3","key":"10.1016\/j.pnpbp.2024.110955_bb0115","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1097\/JCP.0b013e318218dcd5","article-title":"A multicenter, inpatient, phase 2, double-blind, placebo-controlled dose-ranging study of LY2140023 monohydrate in patients with DSM-IV schizophrenia","volume":"31","author":"Kinon","year":"2011","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.pnpbp.2024.110955_bb0120","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.pbb.2018.09.006","article-title":"The effects of donepezil on phencyclidine-induced cognitive deficits in a mouse model of schizophrenia","volume":"175","author":"Li","year":"2018","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.pnpbp.2024.110955_bb0125","doi-asserted-by":"crossref","first-page":"3710363","DOI":"10.1155\/2019\/3710363","article-title":"Glu-mGluR2\/3-ERK signaling regulates apoptosis of hippocampal neurons in diabetic-depression model rats","volume":"2019","author":"Liu","year":"2019","journal-title":"Evid. Based Complement. Alternat. Med."},{"issue":"1","key":"10.1016\/j.pnpbp.2024.110955_bb0130","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20193156","article-title":"Clozapine protects adult neural stem cells from ketamine-induced cell death in correlation with decreased apoptosis and autophagy","volume":"40","author":"Lundberg","year":"2020","journal-title":"Biosci. Rep."},{"key":"10.1016\/j.pnpbp.2024.110955_bb0135","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.neuropharm.2016.08.032","article-title":"Pharmacological and molecular characterization of the positive allosteric modulators of metabotropic glutamate receptor 2","volume":"111","author":"Lundstr\u00f6m","year":"2016","journal-title":"Neuropharmacology"},{"issue":"1\u20133","key":"10.1016\/j.pnpbp.2024.110955_bb0140","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.drugalcdep.2007.08.009","article-title":"Ketamine exposure in adult mice leads to increased cell death in C3H, DBA2 and FVB inbred mouse strains","volume":"92","author":"Majewski-Tiedeken","year":"2008","journal-title":"Drug Alcohol Depend."},{"issue":"18","key":"10.1016\/j.pnpbp.2024.110955_bb0145","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1056\/NEJMra1808803","article-title":"Schizophrenia","volume":"381","author":"Marder","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.pnpbp.2024.110955_bb0150","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.jpsychires.2020.04.005","article-title":"The positive allosteric modulator of the mGlu2 receptor JNJ-46356479 partially improves neuropathological deficits and schizophrenia-like behaviors in a postnatal ketamine mice model","volume":"126","author":"Mart\u00ednez-Pinte\u00f1o","year":"2020","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.pnpbp.2024.110955_bb0155","doi-asserted-by":"crossref","first-page":"114079","DOI":"10.1016\/j.biopha.2022.114079","article-title":"Early treatment with JNJ-46356479, a mGluR2 modulator, improves behavioral and neuropathological deficits in a postnatal ketamine mouse model of schizophrenia","volume":"158","author":"Mart\u00ednez-Pinte\u00f1o","year":"2023","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.pnpbp.2024.110955_bb0160","article-title":"Apoptosis in neural development and disease","volume":"1997","author":"Mazarakis","year":"1997","journal-title":"Arch. Dis. Child. Fetal Neonatal Ed."},{"issue":"1","key":"10.1016\/j.pnpbp.2024.110955_bb0165","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1038\/sj.mp.4001556","article-title":"Treatments for schizophrenia: a critical review of pharmacology and mechanisms of action of antipsychotic drugs","volume":"10","author":"Miyamoto","year":"2005","journal-title":"Mol. Psychiatry"},{"issue":"11","key":"10.1016\/j.pnpbp.2024.110955_bb0170","doi-asserted-by":"crossref","DOI":"10.3390\/antiox11112275","article-title":"Systematic review of the therapeutic role of apoptotic inhibitors in neurodegeneration and their potential use in schizophrenia","volume":"11","author":"Mor\u00e9n","year":"2022","journal-title":"Antioxidants"},{"key":"10.1016\/j.pnpbp.2024.110955_bb0175","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.neulet.2014.11.042","article-title":"Dendritic spine alterations in schizophrenia","volume":"601","author":"Moyer","year":"2015","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.pnpbp.2024.110955_bb0180","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2018.08.016","article-title":"Treatment resistant schizophrenia: clinical, biological, and therapeutic perspectives","volume":"131","author":"Nucifora","year":"2019","journal-title":"Neurobiol. Dis."},{"issue":"1","key":"10.1016\/j.pnpbp.2024.110955_bb0185","doi-asserted-by":"crossref","DOI":"10.1038\/s41398-021-01385-9","article-title":"Glutamate and microglia activation as a driver of dendritic apoptosis: a core pathophysiological mechanism to understand schizophrenia","volume":"11","author":"Parellada","year":"2021","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.pnpbp.2024.110955_bb0190","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0079-6123(08)00906-0","article-title":"Alterations of dopamine and serotonin transmission in schizophrenia","volume":"172","author":"Remington","year":"2008","journal-title":"Prog. Brain Res."},{"issue":"6","key":"10.1016\/j.pnpbp.2024.110955_bb0195","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.tins.2022.03.007","article-title":"Nonapoptotic caspases in neural development and in anesthesia-induced neurotoxicity","volume":"45","author":"Sari\u0107","year":"2022","journal-title":"Trends Neurosci."},{"issue":"2","key":"10.1016\/j.pnpbp.2024.110955_bb0200","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/s00702-006-0440-7","article-title":"Altered NMDA receptor expression and behavior following postnatal hypoxia: potential relevance to schizophrenia","volume":"114","author":"Schmitt","year":"2007","journal-title":"J. Neural Transm."},{"issue":"3","key":"10.1016\/j.pnpbp.2024.110955_bb0205","doi-asserted-by":"crossref","first-page":"2778","DOI":"10.1002\/jcp.27094","article-title":"Ketamine induces reactive oxygen species and enhances autophagy in SV-HUC-1 human uroepithelial cells","volume":"234","author":"Shan","year":"2019","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.pnpbp.2024.110955_bb0210","doi-asserted-by":"crossref","first-page":"190","DOI":"10.3389\/fnsys.2015.00190","article-title":"Hippocampal-prefrontal interactions in cognition, behavior and psychiatric disease","volume":"9","author":"Sigurdsson","year":"2016","journal-title":"Front. Syst. Neurosci."},{"issue":"4","key":"10.1016\/j.pnpbp.2024.110955_bb0215","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1523\/JNEUROSCI.1203-21.2021","article-title":"Sparser and less efficient hippocampal-prefrontal projections account for developmental network dysfunction in a model of psychiatric risk mediated by gene-environment interaction","volume":"42","author":"Song","year":"2022","journal-title":"J. Neurosci."},{"issue":"6","key":"10.1016\/j.pnpbp.2024.110955_bb0220","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.12740\/PP\/OnlineFirst\/99971","article-title":"Analysis of the expression of BAX, BCL2, BIRC6, CASP3, CASP9 apoptosis genes during the first episode of schizophrenia","volume":"53","author":"Szymona","year":"2019","journal-title":"Psychiatr. Pol."},{"issue":"1","key":"10.1016\/j.pnpbp.2024.110955_bb0225","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.schres.2013.05.028","article-title":"Definition and description of schizophrenia in the DSM-5","volume":"150","author":"Tandon","year":"2013","journal-title":"Schizophr. Res."},{"issue":"2","key":"10.1016\/j.pnpbp.2024.110955_bb0230","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.3390\/ijms24021022","article-title":"The effect of clozapine and novel glutamate modulator JNJ-46356479 on nitrosative stress in a postnatal murine ketamine model of schizophrenia","volume":"24","author":"Treder","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.pnpbp.2024.110955_bb0235","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/j.psychres.2013.08.032","article-title":"Bcl-2 associated with positive symptoms of schizophrenic patients in an acute phase","volume":"210","author":"Tsai","year":"2013","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.pnpbp.2024.110955_bb0240","series-title":"PCN FRONTIER REVIEW PCN Glutamate Hypothesis in Schizophrenia","author":"Uno","year":"2019"},{"issue":"5","key":"10.1016\/j.pnpbp.2024.110955_bb0245","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1038\/sj.npp.1301202","article-title":"The role of caspase-3 activation in phencyclidine-induced neuronal death in postnatal rats","volume":"32","author":"Wang","year":"2007","journal-title":"Neuropsychopharmacology"},{"issue":"16","key":"10.1016\/j.pnpbp.2024.110955_bb0250","doi-asserted-by":"crossref","first-page":"3631","DOI":"10.1242\/dev.01928","article-title":"Cellular mechanisms of dendrite pruning in Drosophila: insights from in vivo time-lapse of remodeling dendritic arborizing sensory neurons","volume":"132","author":"Williams","year":"2005","journal-title":"Development"},{"issue":"10","key":"10.1016\/j.pnpbp.2024.110955_bb0255","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1038\/nn1774","article-title":"Local caspase activity directs engulfment of dendrites during pruning","volume":"9","author":"Williams","year":"2006","journal-title":"Nat. Neurosci."},{"issue":"2","key":"10.1016\/j.pnpbp.2024.110955_bb0260","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1016\/j.neuropharm.2006.09.006","article-title":"The odour span task: a novel paradigm for assessing working memory in mice","volume":"52","author":"Young","year":"2007","journal-title":"Neuropharmacology"},{"issue":"6","key":"10.1016\/j.pnpbp.2024.110955_bb0265","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0011374","article-title":"Behavioral consequences of NMDA antagonist-induced neuroapoptosis in the infant mouse brain","volume":"5","author":"Yuede","year":"2010","journal-title":"PLoS One"}],"container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S027858462400023X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S027858462400023X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T20:07:44Z","timestamp":1759522064000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S027858462400023X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":53,"alternative-id":["S027858462400023X"],"URL":"https:\/\/doi.org\/10.1016\/j.pnpbp.2024.110955","relation":{},"ISSN":["0278-5846"],"issn-type":[{"value":"0278-5846","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effects of the PAM of mGluR2, JNJ-46356479, on brain apoptotic protein levels in a mouse model of schizophrenia","name":"articletitle","label":"Article Title"},{"value":"Progress in Neuro-Psychopharmacology and Biological Psychiatry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pnpbp.2024.110955","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"110955"}}